NEW YORK and VANCOUVER, British Columbia, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Bright Minds Biosciences, Inc. ( "Bright Minds," "BMB" or the "Company" ) DRUG, a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and ...

Confirms Deeper High-Grade Zones on Main Break. New Regional Zones at LarderLarge Expansion of Carissa Zone at Deer Trail Points to Mineral Source ...

Investors should take notice when billionaires continue to add to their top holdings. This indicates that their top pick is either attractively priced or has the potential for massive growth.Steve Mandel's firm, Lone Pine Capital, has clear confidence in Meta Platforms ( NASDAQ: META ) .

ALMATY, Kazakhstan, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Joint Stock Company Kaspi.kz ( "Kaspi.kz", "we" ) ( Nasdaq:KSPI ) which operates the Kaspi.kz and Kaspi Pay Super Apps, today published its consolidated IFRS financial results for the quarter and fiscal year ended 31 December 2024 ( "4Q ...

CAMBRIDGE, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Generation Bio Co. GBIO, a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the TD ...

NEW YORK, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- OTC Markets Group Inc. ( OTCQX: OTCM ) , operator of regulated markets for trading 12,000 U.S. and international securities, today announced ZRCN Inc. ( OTCQX: ZRCN ) , is a manufacturer and seller of digitally-enabled hand-tools, has qualified to ...

WELLESLEY HILLS, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. CLYM announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.

WAYNE, Pa. and ROCKVILLE, Md., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Avalo Therapeutics, Inc. AVTX, a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor conferences in March.

BOSTON and SAN DIEGO, Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Rapport Therapeutics, Inc.

WALTHAM, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Syndax Pharmaceuticals ( Nasdaq: SNDX ) , a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its fourth quarter and full year 2024 financial results and ...